StonvexLoading…
StonvexStonvexStonvexCore line items from ATEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-06-17 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $1.60M | $4.54M | $2.97M | $1.42M | $6.03M |
Operating Income | Not available | $74.09M | $83.16M | $22.48M | $-11.71M |
Net Income | Not available | $72.11M | $78.72M | $25.18M | $-11.37M |
EPS (Diluted) | $1.40 | $3.85 | $4.21 | $1.35 | $-0.61 |
Total Assets | Not available | $417.00M | $420.38M | $359.58M | $333.10M |
Total Liabilities | Not available | $181.05M | $180.03M | $174.81M | $176.50M |
Cash & Equivalents | Not available | $29.53M | $39.07M | $41.43M | $47.37M |
Free Cash Flow OCF − CapEx | Not available | $-10.02M | $-1.74M | Not available | $-29.35M |
Shares Outstanding | Not available | 18.73M | 18.71M | 18.70M | 18.61M |